Please login to the form below

Not currently logged in
Email:
Password:

New Merck Foundation appoints Rasha Kelej

She takes up role as CEO of the pharma firm's newly-established non-profit

Rasha KelejRasha Kelej has been appointed chief executive officer for Merck KGaA’s non-profit limited liability company, The Merck Foundation.

Prior to her new position at The Merck Foundation, Kelej has held numerous roles at Merck, including vice president, head of global business for Merck Serono, chief social officer for Merck Group, and subsequently as its senior vice president.

She said: “The Merck Foundation will focus on initiatives that will contribute towards the Sustainable Development Goals outlined by the United Nations.

“To achieve the foundation’s goals, we will develop and implement coherent strategies, result-oriented programs and initiatives, provide grants to support projects and help raise funds where needed.”

Chairman of the board of trustees for The Merck Foundation, Frank Stangenberg-Haverkamp, added: “The vision of the new foundation is a world where everyone can lead a healthy and fulfilling life, also those living under disadvantaged conditions.

“With The Merck Foundation we will continue our commitment towards improving access to innovative healthcare solutions in underserved communities, building healthcare and scientific research capacity and advancing people’s lives through science and technology.”

The Foundation will be chaired by Stangenberg-Haverkamp and he will advise and monitor its performance.

28th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...

Infographics